Blood Thinners and Heart Valve Treatment: What Your Cardiologist Reviews at Each Stage

The pill organizer on the kitchen counter has suddenly become a source of anxiety. For years it was routine: a warfarin tablet with breakfast, a clinic visit for the blood test, a quiet adjustment now and then. Now there is a surgery date, a stack of leaflets about valves made of carbon or cow tissue, and one question that keeps surfacing at 3 a.m.: what exactly happens to the blood thinners before valve surgery, and who is making sure nothing is missed?

The honest answer is that this is one of the most carefully choreographed parts of heart surgery. Anticoagulation before, during and after a valve procedure is reviewed at fixed checkpoints by the cardiologist, the surgeon, the anesthetist and the pharmacy team, each looking at the same two risks from different angles: too much clotting, and too much bleeding.

This explainer walks through those checkpoints in the order you will meet them, so the stack of leaflets starts to make sense and the 3 a.m. questions become daytime questions for your care team.

Why blood thinners before valve surgery get their own review

Heart valve surgery sits at an unusual crossroads. The operation itself creates a bleeding risk that few other procedures match: the chest is opened, the heart is often stopped and connected to a bypass machine, and the machine’s own tubing requires heavy anticoagulation during the operation. At the same time, the reason many patients are on a blood thinner in the first place, such as atrial fibrillation, a previous clot or an existing artificial valve, does not go away on the morning of surgery.

That is why anticoagulation gets a dedicated review rather than a line on a generic pre-operative checklist. The cardiologist will want to know which medicine you take, why you take it, how stable your levels have been, how well your kidneys clear the drug, and whether you have had bleeding or clotting problems in the past. Each answer shifts the plan.

Think of it as balancing a seesaw. On one end sits the chance of a clot forming while the blood thinner is paused; on the other sits the chance of bleeding during or after the operation if it is not paused long enough. The ACC/AHA valvular heart disease guideline frames almost every anticoagulation decision around that balance, and it is explicit that the decision should be individualized rather than applied as a single rule for everyone.

For the patient, the practical point is simple. Do not stop, skip or double any blood thinner on your own initiative before surgery. The timing is worked out for you, written down, and usually confirmed by telephone or at a pre-assessment visit. If the instructions are unclear or you lose the paperwork, ask again. A ten-minute call is far easier than untangling a missed dose on the day of admission.

How blood thinners actually work: the classes you will hear about

The phrase “blood thinner” is a convenient shorthand, but the medicines do not thin anything. They slow or block specific steps in clotting, and they fall into a few families that behave very differently around surgery.

Vitamin K antagonists. Warfarin is the familiar example. It blocks the liver’s use of vitamin K to make several clotting proteins. Because those proteins already circulating must wear out before the effect appears, warfarin takes several days to start working and several days to wear off, which MedlinePlus describes in its patient information. Its effect is measured by the INR, a standardized blood test that reports how long the blood takes to clot compared with normal.

Heparins. These are injectable anticoagulants. Unfractionated heparin, given by drip in hospital, acts within minutes and fades within hours of stopping. Low molecular weight heparins, given by injection under the skin, last roughly a day. Their speed makes them the tool of choice when a long-acting medicine needs a temporary stand-in.

Direct oral anticoagulants (DOACs). This newer class blocks a single clotting factor directly. They act within hours and clear within a day or two in people with normal kidney function, so they need no routine blood monitoring. They have a specific limitation in valve care that we return to below.

Antiplatelet medicines. Aspirin and related drugs act on platelets, the cell fragments that form the first plug at a damaged surface, rather than on clotting proteins. They are often used around tissue valves and catheter-based valve procedures.

The MedlinePlus overview of blood thinners is a reliable starting point if you want a fuller description of each group. Knowing which family your medicine belongs to explains most of what follows: a drug that lingers for days needs a different exit plan from one that is gone by tomorrow.

Stopping blood thinners before heart surgery: what the days before look like

The pre-operative plan is a countdown, and it is set by how long each medicine stays active in the body.

For warfarin, surgical guidance generally describes pausing the medicine several days before a planned operation, commonly around five days, so that the INR can drift back toward normal in time for surgery; the ACC/AHA guideline discusses this timing in its peri-procedural anticoagulation section. The INR is usually rechecked shortly before the operation. If it is still higher than the surgical team wants, the procedure may be delayed, or vitamin K may be given to speed the reversal. Vitamin K is not a dangerous intervention, but it does make warfarin harder to restart smoothly afterwards, so teams use it selectively.

For DOACs the window is shorter, typically one to a few days depending on the drug, the kidney function and how much bleeding the operation involves. The exact interval is set by the prescribing clinician using kidney blood tests from the pre-assessment visit.

Antiplatelet medicines are handled individually. Aspirin is sometimes continued straight through valve surgery when the team judges the clot-prevention benefit outweighs the added bleeding; more potent antiplatelet drugs are usually paused. Neither decision is a judgment on how “important” your medicine is, only on how it behaves in an operating room.

What the patient experiences during this countdown is usually undramatic: a written stop date, a blood test, and a phone call confirming the plan. The NHS warfarin guidance stresses carrying your anticoagulant alert card and telling every clinician, including the dentist and the pre-assessment nurse, which medicine you take and when you last took it. That last detail matters more than almost anything else in the pre-operative conversation.

How to bridge from warfarin to heparin, and who actually needs it

“Bridging” is the term for covering the gap while warfarin is paused by using a short-acting injectable anticoagulant, usually a low molecular weight heparin at home or an unfractionated heparin drip in hospital. The idea is straightforward: the heparin takes over clot prevention while the warfarin effect fades, is itself stopped close to the operation because it clears quickly, and is restarted afterwards until warfarin is working again.

Not everyone who takes warfarin is bridged. The decision rests on how likely a clot is during a few unprotected days. The ACC/AHA guideline singles out several higher-risk situations where bridging is generally recommended: a mechanical valve in the mitral position, an older-generation mechanical aortic valve, a mechanical valve plus additional risk factors such as atrial fibrillation or a previous clot, or a recent stroke or clot. For a person with a modern mechanical aortic valve and no other risk factors, the same guideline notes that a brief pause without bridging is often reasonable.

Here is what bridging commonly involves in practice:

• A stop date for warfarin, set by the team.
• Injections of a low molecular weight heparin starting a day or two after the last warfarin dose, taught by a nurse if given at home.
• A final pre-operative injection timed well before the operation, with the exact gap specified by the anesthetic team.
• Restarting of heparin after surgery once the surgeon is satisfied bleeding has settled.
• Overlap of heparin and warfarin until the INR is back in the target range, then heparin stops.

Every timing in that list is individualized, which is why no reputable patient resource publishes a universal schedule. If your team has decided not to bridge you, that is not an oversight; it usually reflects a careful judgment that the brief clotting risk is lower than the bleeding risk the heparin would add.

Who is usually asked to wait, and who goes ahead

Most valve operations are planned weeks ahead, and the anticoagulation review is one of several reasons a date can move. Understanding the usual reasons helps a delay feel less like a setback.

Patients are commonly asked to wait when the INR on the day before surgery remains above the level the surgical team has set, when a recent clot or stroke means stopping anticoagulation is unsafe for now, when a new infection is being treated, or when kidney function has changed and the exit timing for a DOAC needs recalculating. A dental review is another frequent reason. Because an artificial valve is vulnerable to infection from bacteria entering the bloodstream, many teams ask for dental problems to be sorted before implantation, and the Mayo Clinic lists this among routine preparations.

Patients who tend to go ahead without delay are those whose anticoagulation has been stable, whose pre-operative blood tests are in range, and whose plan has been confirmed in writing. People who take no anticoagulant at all, as is true of many with aortic stenosis, have a simpler pathway and may only need to confirm whether an antiplatelet is continued.

The urgent case is different. When a valve is failing acutely, when infection has eaten into valve tissue, or when a clot has jammed a mechanical valve, waiting may not be an option. Surgeons then operate with the anticoagulant still active and manage bleeding with reversal agents, clotting factor concentrates or transfusion. This is riskier, and teams accept that risk only when the alternative is worse.

Whichever group you fall into, the final call sits with the operating team on the day. A good pre-assessment service will tell you not only the plan but the reasons behind it, and will tell you who to phone if anything changes in the days before admission.

Mechanical or tissue valve: the choice that sets your blood thinner plan for years

The single biggest influence on anticoagulation after valve replacement is decided before the operation: which kind of valve goes in. The two families trade durability against the need for lifelong warfarin, and the trade-off deserves an unhurried conversation.

A mechanical valve is made from pyrolytic carbon and metal. It does not wear out in a normal lifetime, but blood recognizes its surface as foreign and clots readily on it, so a vitamin K antagonist is required for as long as the valve is in place. A tissue valve, also called a bioprosthesis, is built from treated animal tissue, usually from a cow or pig, or occasionally from a human donor. Blood tolerates it far better, so long-term warfarin is usually unnecessary, but the tissue stiffens and wears over time. The American Heart Association notes that tissue valves often need replacing after roughly one to two decades, with faster wear in younger patients.

Feature	Mechanical valve	Tissue (bioprosthetic) valve
Material	Carbon and metal	Treated animal or donor tissue
Expected durability	Designed to last a lifetime	Often 10–20 years, less in younger people
Long-term anticoagulation	Warfarin for life	Usually a few months, then often antiplatelet or none
Regular INR testing	Yes, ongoing	Only during any warfarin period
Sound	Faint click some patients notice	Silent
Likelihood of repeat procedure	Low for valve wear	Higher as the valve ages

Age, lifestyle, pregnancy plans, bleeding history, kidney disease and personal preference all feed into the choice. The ACC/AHA guideline describes a shared decision in which younger patients lean toward mechanical valves and older patients toward tissue, with a broad middle zone where either is reasonable. Neither option is objectively better; the right one is the one whose trade-offs fit your life.

Warfarin and mechanical heart valve: do you have to take it?

Yes, for as long as the mechanical valve is in place, and this is one of the few areas of cardiology where the evidence allows an unqualified answer. Without a vitamin K antagonist, clot forms on the valve’s hinges and leaflets. A clot can jam the valve, which is a surgical emergency, or break off and travel to the brain, causing a stroke. The ACC/AHA guideline gives lifelong warfarin for mechanical valves its strongest class of recommendation.

A natural follow-up question is whether one of the newer DOACs could replace warfarin and spare the blood tests. The answer, for now, is no. A randomized trial that compared a DOAC with warfarin in mechanical valve patients was stopped early because the DOAC group had more clots and more bleeding, and the guideline consequently states that DOACs should not be used with mechanical valves. The reason is thought to be mechanistic: the clotting cascade triggered by a foreign surface is broad, and blocking a single factor does not restrain it the way warfarin’s multi-factor effect does. Research continues, but no DOAC has been shown safe in this setting.

Many teams add a low-dose antiplatelet to warfarin for mechanical valve patients who have additional clot risk or who have had a clot despite a good INR. That is a clinician’s judgment, weighed against bleeding risk, and not something to add yourself.

Living with warfarin is less restrictive than many people expect. The NHS describes a routine of regular INR tests, which can often be done at a local clinic or with a home finger-prick device, a consistent rather than restrictive diet, and a habit of mentioning the medicine to every prescriber. The medicine asks for attention, not for a smaller life.

Anticoagulation after valve replacement: the first days in hospital

The operation ends, but the anticoagulation story simply changes chapter. In the operating room the bypass machine required a large dose of heparin, which the anesthetist reverses with a specific antidote before the chest is closed. The first hours in intensive care are then about watching for bleeding: chest drains are checked, blood counts are repeated, and anticoagulants are deliberately held.

Once the surgeon is confident the raw surfaces inside the chest have sealed, usually within the first day or two, restarting begins. For a mechanical valve, warfarin is typically restarted early, often on the first or second post-operative day, with heparin used as a bridge until the INR reaches the target range. For a tissue valve, the team decides between a few months of warfarin, an antiplatelet alone, or in some cases nothing beyond standard post-operative clot prevention. The ACC/AHA guideline considers a period of warfarin reasonable after a surgical tissue valve when bleeding risk is low, commonly for around three to six months while the sewing ring becomes covered by the body’s own lining.

Patients often notice a flurry of injections during this period. Some are the heparin bridge; others are the routine blood thinner that every surgical patient receives to prevent leg clots while mobility is reduced. It is reasonable to ask which is which.

Two complications are watched for closely. The first is bleeding into the sac around the heart, which can compress it and cause low blood pressure and breathlessness; this is why anticoagulation is introduced gradually rather than at full intensity on day one. The second is a drop in platelet count caused by an immune reaction to heparin, which sounds paradoxical but is a recognized cause of clotting. Blood counts every day or two catch it early.

Before discharge, expect a clear written plan: the medicine, the date of the next INR test if relevant, who manages it, and what to do if a dose is missed. Hospital stays after open valve surgery are often about a week according to the NHS, so this handover happens quickly.

How long does the heart take to heal after aortic valve replacement?

Healing happens on several clocks at once, and it helps to separate them, because the blood thinner plan tracks some clocks and not others.

The breastbone is the slowest. It is wired back together and knits like any other broken bone, which is why lifting, pushing and driving are restricted for weeks. The NHS describes a full recovery from aortic valve replacement as commonly taking two to three months, with most people able to return to driving and light work somewhere in that window once cleared by their team.

The heart muscle has its own timetable. A valve that was narrowed or leaking for years left the heart thickened or stretched; once the valve works properly, that remodelling partially reverses over months. Energy and breathlessness often improve before the heart’s structure has fully changed, which is why follow-up echocardiograms continue well after you feel better.

The valve itself heals, in a sense, over the first few months. The body lays down a smooth lining over the sewing ring and struts, reducing the raw surface that attracts clot. This is the biological reason behind the few-months warfarin period after a surgical tissue valve: once the lining is complete, the clotting risk falls and the medicine can often be stepped down or stopped on the team’s instruction.

Through all of this, the anticoagulation plan is reviewed at each outpatient visit. Typical checkpoints include the first INR test within days of discharge for warfarin patients, a surgical wound and chest X-ray review at a few weeks, and an echocardiogram and medicine review at a few months. Cardiac rehabilitation, which the Mayo Clinic recommends after valve surgery, runs alongside and is also where many people learn how anticoagulation interacts with exercise, alcohol and travel.

None of these ranges is a promise. Older age, other illnesses, and complications all stretch them, and your own team’s advice replaces any general figure.

Tissue valves and catheter procedures: shorter blood thinner courses, different choices

Not every valve treatment involves a saw and a bypass machine, and the anticoagulation plan reflects that. Transcatheter aortic valve replacement, usually shortened to TAVR or TAVI, threads a folded tissue valve through an artery in the groin and expands it inside the diseased valve. There is no breastbone to heal and no sewing ring in the same sense, so the post-procedure medicine plan leans toward antiplatelet drugs rather than warfarin.

The ACC/AHA guideline describes aspirin alone as a reasonable long-term choice after TAVR for people with no other reason to be anticoagulated, with the option of a limited period of a second antiplatelet drug. Patients who already take an anticoagulant for atrial fibrillation usually continue it, and the team decides whether an antiplatelet is added at all, since combining the two raises bleeding risk. Trials in recent years have generally favored fewer medicines rather than more after TAVR, a trend the Mayo Clinic patient information reflects when it notes that medicine plans are individualized.

A surgically implanted tissue valve sits between the two extremes. Many patients receive a few months of warfarin, as described above, then move to an antiplatelet or to no routine blood thinner if they have no other indication. Others, especially those at higher bleeding risk, go straight to an antiplatelet.

One subtle point trips up many people with tissue valves and atrial fibrillation: the valve may not need warfarin, but the rhythm disorder still needs an anticoagulant. For them, a DOAC is often acceptable, because the restriction on DOACs applies to mechanical valves and to rheumatic narrowing of the mitral valve, not to tissue valves. Which medicine is used, and when, is a decision for the prescribing cardiologist with the full picture of your valve, your rhythm and your bleeding history in front of them.

INR testing, vitamin K and interactions: the routine that keeps a mechanical valve safe

For anyone on warfarin after valve surgery, the INR becomes a familiar number. The test measures how long a blood sample takes to clot relative to a standardized normal, so an INR of 1 is normal clotting and higher numbers mean slower clotting. Your team sets a target range for your valve type and position, and the goal is to spend as much time as possible inside it. Too low and clot risk rises; too high and bleeding risk rises.

Many things nudge the INR, which is why testing is regular rather than occasional. The NHS and MedlinePlus both highlight the main influences:

• Vitamin K in food, concentrated in leafy greens, works against warfarin. The advice is consistency, not avoidance: eat a steady amount week to week so your dose can be matched to it.
• Antibiotics, antifungals, some pain relievers and many herbal products change how warfarin is cleared or how platelets behave.
• Alcohol in large or irregular amounts destabilizes the INR.
• Illness with vomiting, diarrhea or poor appetite can push the INR up within days.

Testing is now flexible. Many people use anticoagulation clinics; others are trained to use a home finger-prick meter and report results by phone or app, with a clinician making any adjustment. Home testing has made frequent checks far less disruptive, and the guideline notes it is reasonable for suitable patients.

Two habits make the biggest difference. First, tell every prescriber, pharmacist and dentist that you take warfarin for a heart valve before anything new is started. Second, never adjust your own dose in response to a result or a missed tablet; call the clinic that manages your INR. Adjustments depend on the pattern over weeks, not on one reading, and the people who see that pattern are best placed to act on it.

What people often get wrong about blood thinners and heart valves

Some misunderstandings surface so regularly in clinic that they deserve direct correction.

“If I feel fine, the warfarin must be working.” Warfarin has no symptoms when it is in range and few when it is out of range until something goes wrong. Only the INR tells you where you stand, which is why testing continues even when life feels completely normal.

“Blood thinners thin the blood, so I’ll bruise and bleed with every knock.” The medicines slow clotting; they do not change the blood’s thickness. Bruising more easily is real, but spontaneous serious bleeding at a well-controlled INR is uncommon, and most people on warfarin garden, travel and play sport.

“I should stop my blood thinner a week before any procedure, just to be safe.” Stopping without a plan is the single most dangerous thing a mechanical valve patient can do. Many dental and minor procedures can be done without stopping at all, and when a pause is needed the timing is set by the team, sometimes with bridging.

“A newer anticoagulant would be safer than warfarin.” For atrial fibrillation without a mechanical valve that is often true. For a mechanical valve the trial evidence showed the opposite, and the guideline advises against DOACs in this setting.

“I have to give up green vegetables.” You have to be consistent, which is a different thing entirely. A steady intake lets your clinic set a stable dose around it.

“Once the tissue valve is in, blood thinners are over for good.” Often true for the valve itself, but a separate rhythm problem or clot history can still require anticoagulation, and the body’s lining over the valve takes months to form, hence the common early warfarin course.

“The surgeon handles the blood thinner; the cardiologist handles the heart.” In practice it is a shared responsibility that passes between surgeon, cardiologist, anticoagulation clinic and family doctor at agreed points. Knowing who holds the plan at each stage is a question worth asking before you leave hospital.

Questions to ask your care team about anticoagulation around valve surgery

Consultations are short and the subject is complex, so a written list helps. These questions cover the points patients most often say they wish they had raised earlier.

• Which blood thinner am I on, why was it chosen for me, and will the same medicine continue after surgery?
• On what date should I take my last dose before the operation, and who do I call if I am unsure whether I took it?
• Will I be bridged with an injectable anticoagulant, and if not, what is the reasoning?
• If I am bridged, will the injections be given at home or in hospital, and who teaches me?
• Should I keep taking aspirin or any other antiplatelet through the operation?
• Which other medicines, supplements or herbal products should I pause, and when?
• Have we agreed on a mechanical or tissue valve, and how does that change my long-term anticoagulation?
• If I am having a tissue valve, how long will I be on a blood thinner afterwards, and what decides when it stops?
• Who manages my INR after discharge, how soon is the first test, and is home testing an option for me?
• What should I do about anticoagulation if I need another operation, a dental extraction or an endoscopy in the future?
• What are the specific warning signs that should make me call, and what number do I use out of hours?
• Do I need antibiotic cover before dental work with my new valve, and who prescribes it?

Bring the answers home in writing. Several hospitals issue an anticoagulant alert card and a yellow or orange booklet for recording INR results; keeping both with your other documents, and photographing them, avoids a scramble if you are seen somewhere unfamiliar. If English is not your first language, ask whether written instructions are available in your preferred language or whether an interpreter can join the pre-assessment call, because the timing details in this plan are too important to leave to guesswork.

When to call your doctor: red flags before and after valve surgery

Anticoagulation around valve surgery is safe when it is watched, and watching includes you. Some signs need an urgent call to your team or emergency services; others warrant a same-day call to whoever manages your blood thinner.

Call emergency services immediately for any of the following:

• Sudden weakness or numbness of the face, arm or leg, trouble speaking, or sudden loss of vision, which may indicate a stroke from a clot or a bleed.
• Sudden severe headache unlike any you have had before.
• Vomiting blood, or passing black, tarry or bright red stools.
• New chest pain, sudden breathlessness, fainting or a racing heartbeat, which after valve surgery can signal bleeding around the heart or a problem with the valve.
• A mechanical valve click that has become faint or has disappeared, together with breathlessness.

Call your team the same day if you notice:

• Fever, chills or night sweats in the weeks or months after surgery; infection of a prosthetic valve can begin quietly and needs prompt assessment, as the Mayo Clinic notes.
• Nosebleeds that will not stop, blood in the urine, heavy menstrual bleeding or large unexplained bruises.
• Redness, swelling, oozing or separation at the chest wound.
• Pain or swelling in one calf.
• Vomiting or diarrhea lasting more than a day while on warfarin, or any new medicine started by another clinician.
• A missed or doubled dose, or an INR result outside your range.

Before surgery, call if you develop an infection, a new bleeding problem or any doubt about your stop date. After surgery, err on the side of calling. Teams would much rather hear about a false alarm than about a delay. Every decision about pausing, restarting or changing an anticoagulant belongs to the clinicians who know your valve and your history; this article is a map, not the territory.

Frequently asked questions

What medication is used to treat a prosthetic heart valve?

The medicine depends on the valve type. Mechanical valves require a vitamin K antagonist such as warfarin for life, sometimes with a low-dose antiplatelet added by the cardiologist. Tissue valves usually need a shorter warfarin course of a few months, followed by an antiplatelet or no routine blood thinner. After catheter-based valve replacement, antiplatelet therapy is common. Your team selects the regimen based on valve position, rhythm, and bleeding history.

Do you have to take warfarin with a mechanical valve?

Yes, for as long as the mechanical valve is in place. Blood clots readily on the valve’s artificial surface, and without a vitamin K antagonist those clots can jam the valve or travel to the brain. Guidelines give lifelong warfarin for mechanical valves their strongest recommendation, and direct oral anticoagulants are specifically advised against after a trial showed more clots and bleeding with that class.

How is bridging warfarin to heparin usually done?

Warfarin is stopped several days before surgery, and once its effect begins to fade, a short-acting injectable heparin takes over clot prevention. The heparin is paused shortly before the operation because it clears within hours, restarted once post-operative bleeding has settled, and continued alongside warfarin until the INR is back in range. Every timing is set individually by the surgical and cardiology team.

Does everyone on blood thinners before valve surgery need bridging?

No. Bridging adds bleeding risk, so it is used when the risk of a clot during the pause is high: a mechanical mitral valve, an older mechanical aortic valve, a mechanical valve with atrial fibrillation or previous clot, or a recent stroke. People taking a DOAC are rarely bridged because the drug clears quickly, and someone with a modern mechanical aortic valve alone may be managed with a brief pause.

How long does it take for the heart to heal after aortic valve replacement?

Full recovery from open aortic valve replacement commonly takes two to three months according to NHS guidance, with hospital stays often around a week. The breastbone heals over several weeks, heart muscle remodels over months, and the body lines the new valve over the first few months. These are typical ranges, not promises, and your team’s advice about driving, lifting and work overrides any general figure.

How long do you take anticoagulation after valve replacement with a tissue valve?

Many patients with a surgically implanted tissue valve take warfarin for roughly three to six months while the body’s lining forms over the sewing ring, a period the ACC/AHA guideline considers reasonable when bleeding risk is low. After that, teams often switch to an antiplatelet or stop routine blood thinners altogether, unless a separate condition such as atrial fibrillation still requires anticoagulation.

Can I take a newer blood thinner instead of warfarin with a mechanical valve?

Not at present. A randomized trial that compared a direct oral anticoagulant with warfarin in mechanical valve patients was stopped early because of more clots and more bleeding in the DOAC group, and guidelines now advise against DOACs in this setting. The restriction applies to mechanical valves and rheumatic mitral narrowing; people with tissue valves who need anticoagulation for atrial fibrillation may be offered a DOAC.

Is stopping blood thinners before heart surgery dangerous?

An unplanned stop can be dangerous, especially with a mechanical valve, because clot risk rises within days. A planned pause arranged by your team is a different matter: the timing is calculated from how long the medicine stays active, the INR is checked before the operation, and higher-risk patients receive a heparin bridge. Never stop or skip a blood thinner before surgery without written instructions from your clinicians.

Do I have to avoid leafy green vegetables on warfarin after valve surgery?

No. Vitamin K in greens works against warfarin, but the advice from the NHS and MedlinePlus is consistency rather than avoidance. Eating a similar amount each week lets your anticoagulation clinic match your dose to your diet and keep the INR stable. Sudden large changes in either direction, such as starting a new diet or stopping greens entirely, are what cause the INR to swing.

Who manages my blood thinner after I leave hospital?

Responsibility usually passes from the surgical team to an anticoagulation clinic, a cardiologist, or a family doctor, and the handover should be written down before discharge. Ask who performs the first INR test, how soon it is due, whether home testing is an option, and which number to call about missed doses or new medicines. Knowing who holds the plan at each stage prevents gaps in care.

References

• Blood Thinners (MedlinePlus)
• Warfarin: Drug Information (MedlinePlus)
• Aortic valve replacement: Recovery (NHS)
• Warfarin (NHS)

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.